Swartz Robin 4
4 · Voyager Therapeutics, Inc. · Filed Feb 26, 2026
Research Summary
AI-generated summary of this filing
Voyager (VYGR) COO Robin Swartz Sells 6,458 Shares
What Happened
- Robin Swartz, Chief Operating Officer & Chief Business Officer of Voyager Therapeutics (VYGR), disposed of 6,458 shares on 2026-02-24. The reported weighted-average price was $3.77 per share, for total proceeds of $24,347. The shares were sold under an automatic sell-to-cover instruction to satisfy tax withholding related to RSUs that vested on Feb 21, 2026; the sale was not a discretionary trade by the reporting person.
Key Details
- Transaction date: 2026-02-24; Form filed: 2026-02-26.
- Sale details: 6,458 shares sold; weighted-average price $3.77; sale prices ranged $3.61–$3.86 (sold in multiple transactions).
- Shares owned after transaction: not specified in the provided summary (see the Form 4 for post-transaction holdings).
- Footnotes: F1 — sale pursuant to durable automatic sell-to-cover instruction adopted 2025-05-12 to satisfy RSU tax withholding; F2 — weighted-average price reported, reporting person will provide per-price breakdown on request.
- Transaction code: S (Sale). No lateness flag indicated in the provided data.
Context
- This was a routine sell-to-cover tied to RSU vesting (tax withholding), not an open-market discretionary sell; such transactions are administrative and do not necessarily signal insider sentiment. Purchases or discretionary sales typically carry more signal for investor interpretation.
Insider Transaction Report
Form 4
Swartz Robin
COO & CBO
Transactions
- Sale
Common Stock
[F1][F2]2026-02-24$3.77/sh−6,458$24,347→ 199,738 total
Footnotes (2)
- [F1]Represents shares of common stock of Voyager Therapeutics, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 12, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 21, 2026. The sales do not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.86, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Signature
/s/ Gregory L. Shiferman, as Attorney-in-Fact for Robin Swartz|2026-02-26